First Gene Treatment For Early Bladder Cancer Okayed By FDA
The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or...
The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or...
The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy...
The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements...
The global Alzheimer's therapeutics market is anticipated to develop at a compound annual growth rate (CAGR) of 9.3%Â and reach $6.8...
The pharmaceutical sector has grown quickly in recent years, and by 2023 it is anticipated to reach USD 1.5 trillion....
The needs of manufacturing facilities, tools, and procedures must be suitable for this new environment as the focus of new...
Who will file a lawsuit under the UPC first? The deadline for opting out of patents will begin on March...
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies...
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and...
A mechanism that employs urea to begin the manufacturing of proteins in the massive amounts required by the biotech industry...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.